60d FRN published

khammond on DSKJM1Z7X2PROD with NOTICES

Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
• What are best practices for using ecare plans to facilitate communication
among people at risk for or living with
MCC, their caregivers, clinicians, and
health care teams, and provide a shared
resource for documenting goals,
treatments and supports, education and
self-management, along with other
patient-generated health data?
• What are promising approaches for
systematically identifying and
addressing social determinants of
health?
• Are there any programmatic
adaptations that would address the
cultural and linguistic considerations
when working with minority
populations?
• How can equity be ensured in
person-centered care planning?
• What are active areas of research
and gaps in knowledge?
AHRQ is interested in all of the
questions listed above, but respondents
are welcome to address as many or as
few as they choose and to address
additional areas of interest regarding
comprehensive longitudinal personcentered care planning not listed. It is
helpful to identify the question to which
a particular answer corresponds.
This RFI is for planning purposes
only and should not be construed as a
policy, solicitation for applications, or
as an obligation on the part of the
Government to provide support for any
ideas in response to it. AHRQ will use
the information submitted in response
to this RFI at its discretion and will not
provide comments to any respondent’s
submission. However, responses to this
RFI may be reflected in future
solicitation(s) or policies. The
information provided will be analyzed
and may appear in reports. Respondents
will not be identified in any published
reports. Respondents are advised that
the Government is under no obligation
to acknowledge receipt of the
information received or provide
feedback to respondents with respect to
any information submitted. No
proprietary, classified, confidential or
sensitive information should be
included in your response. The contents
of all submissions will be made
available to the public upon request.
Submitted materials must be publicly
available or able to be made public.
Dated: September 12, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–20027 Filed 9–15–22; 8:45 am]
BILLING CODE 4160–90–P

VerDate Sep<11>2014

16:43 Sep 15, 2022

Jkt 256001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22IU; Docket No. CDC–2022–
0110]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Evaluation of
the CDC/NIOSH Health Worker Mental
Health Campaign. This project will
collect data through the administration
of online surveys to health workers and
their employers prior to campaign
launch and 12 months afterward to
assess changes in relevant knowledge,
attitudes, and beliefs to help inform
recommendations.

SUMMARY:

CDC must receive written
comments on or before November 15,
2022.

DATES:

You may submit comments,
identified by Docket No. CDC–2022–
0110 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
ADDRESSES:

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

56953

Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Education and Awareness
Social Marketing Campaign: Employer
Efforts to Support the Mental Health of
Health Workers—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
As part of the COVID–19 American
Rescue Plan of 2021, in response to a
congressional mandate, and on the heels
of the passage of the Dr. Lorna Breen
Health Care Provider Protection Act, the
National Institute for Occupational
Safety and Health (NIOSH), within the
Centers for Disease Control and

E:\FR\FM\16SEN1.SGM

16SEN1

56954

Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices

Prevention (CDC), is taking an active
stance to address mental health
concerns among the more than 20
million workers in the nation’s
healthcare sector. For many years now,
health workers have reported feeling
undervalued, overworked, and
overwhelmed. A 2012 study that
surveyed more than 7,000 physicians
found that nearly half of them had
symptoms of burnout. The COVID–19
pandemic has only exacerbated the
strain and pressure facing health
workers as they endure unprecedented
challenges that make working in this
field exponentially harder on their own
health and wellbeing. So much so, that
the wellbeing of those who dedicate
their days and nights to keeping us
healthy has surpassed a point of crisis.
Depression, anxiety, and PTSD are
highly prevalent among health workers
across the United States. A systematic
review of studies addressing burnout
among nurses found that more than a
third (34.1%) had emotional exhaustion.
A 2020 survey of healthcare workers
found that 86% reported experiencing
anxiety, and 39% did not feel like they
had adequate emotional support.
While many Americans experienced
some respite from COVID–19 over the
last 24 months, health workers
remained on the front lines, in
communities and health systems where
infections and deaths remained highest
and in settings where their charge was
to care of the sickest and most
immunocompromised Americans. Add
to this staffing shortages, a lack of
resources and beds across health centers
of all sizes, public mistrust in medical
professionals in certain areas, and
hesitancy of health workers to access
support due to licensure and

seeking and care in those healthcare
organizations participating in social
marketing efforts.
Outcome data collected for the nonexperimental study will include a
representative sample of 3,000 health
workers and 500 high-level healthcare
executives that hail from relevant
partner network organizations of the All
In network. The survey will be
completed on a rolling basis at baseline
(pre-launch) and at 12-months post
baseline. A new representative sample
will be drawn at each data collection
period. The health worker survey
should take no more than 21 minutes to
complete; the executive survey no more
than 15 minutes.
Outcome data collected for the quasiexperimental study will include 960
health workers and 60 high-level
executives that hail from 12 clinical
sites (six intervention sites and six
comparison sites) affiliated with our
existing partner hospital systems.
Unlike the non-experimental study, the
same participants will be asked to
complete both the baseline and 12month follow-up surveys (as matched
pairs). The health worker survey should
take no more than 21 minutes to
complete; the executive survey no more
than 15 minutes. In addition, up to 18
health workers at each of the six
intervention sites will participate in a
60-minute, in-depth interview (nine
workers at baseline and another nine at
12 months); and two senior
administrators from each of the six
intervention sites will participate in a
45-minute-long interview at 12 months.
CDC requests OMB approval for an
estimated 1,427 annual burden hours.
There is no cost to respondents other
than their time to participate.

credentialing issues, it is no wonder that
our nation’s health workers need
support, especially from the systems
that employ them.
NIOSH, the federal agency tasked
with conducting research to contribute
to reductions in occupational illnesses,
injuries, and hazards, and its contractor,
JPA Health, plan to develop, implement,
and evaluate a social marketing
campaign that aims to raise health
worker and healthcare executive
awareness of mental health risks,
promote help seeking and treatment
among health workers experiencing
burnout and job-related distress, reduce
stigma associated with health workers’
mental health help seeking, and
establish organizational policies and
practices that support worker mental
health. For NIOSH, this project requires
more than a messaging campaign and
aims to marry communications best
practices with behavior and systems
change strategies to start addressing the
working conditions that contribute to
job-related distress, structural barriers
that prevent health workers from
seeking help, and healthcare executives
from providing mental health services
and supports.
While many individual-level
interventions specific to healthcare and
healthcare workers exist, very few
interventions address the organizational
level causes of health worker burnout. It
is for this reason that we are proposing
a two-year approval to collect data that
will allow us to determine whether the
social marketing campaign is reaching
and engaging executives who will, in
turn, support and facilitate
modifications to working conditions
that contribute to job-related distress;
and whether the campaign is associated
with increased mental health help

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents

Health Worker ................
Health Worker ................
Executive .......................

khammond on DSKJM1Z7X2PROD with NOTICES

Executive .......................
Health Worker ................
Health Worker ................
Health Worker ................
Executive .......................
Executive .......................

VerDate Sep<11>2014

Number of
respondents

Form name

Partner Network Member
(Form 1).
Partner Network Member
(Form 2).
Partner Network Member
(Form 3).
Partner Network Member
(Form 4).
Quasi-experimental Study
(Form 5).
Quasi-Experimental Study
Comparison (Form 6).
Quasi-Experimental Study
Intervention (Form 7).
Quasi-Experimental Baseline
Quasi-Experimental Study
Comparison (Form 9).

16:43 Sep 15, 2022

Jkt 256001

PO 00000

Baseline

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total burden
hours

Survey

1,500

1

15/60

375

Follow-up Survey

1,500

1

21/60

525

Survey

250

1

10/60

42

Follow-up Survey

250

1

15/60

125

Baseline

Survey

480

1

15/60

120

Follow-up

Survey

240

1

21/60

84

Follow-up

Survey

240

1

21/60

84

Survey (Form 8) ...
Follow-up Survey

30
15

1
1

10/60
15/60

5
4

Baseline

Frm 00029

Fmt 4703

Sfmt 4703

E:\FR\FM\16SEN1.SGM

16SEN1

56955

Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)

Total burden
hours

Form name

Executive .......................

Quasi-Experimental Study Follow-up Survey
Intervention (Form 10).
Quasi-Experimental Study Baseline Interview
Intervention (Form 11).
Quasi Experimental Study Follow-up Interview
Intervention (Form 12).
Quasi-Experimental Study Follow-up Interview
Intervention (Form 15).

15

1

15/60

4

27

1

60/60

27

27

1

60/60

27

6

1

45/60

5

..............................................................................

........................

........................

........................

1,427

Health Worker ................
Health Worker ................
Executive .......................
Total ........................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–20121 Filed 9–15–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0004; Docket No. CDC–2022–
0108]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

Notice with comment period.

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National Disease
Surveillance Program—II. Disease
Summaries information collection. This
collection is used to determine the
prevalence of disease and for planning
and evaluating programs for prevention
and control of infectious diseases.

SUMMARY:

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

CDC must receive written
comments on or before November 15,
2022.

DATES:

You may submit comments,
identified by Docket No. CDC–2022–
0108 by either of the following methods:

ADDRESSES:

VerDate Sep<11>2014

16:43 Sep 15, 2022

Jkt 256001

• Federal eRulemaking Portal:
www.regulations.gov Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance
Program II—Disease Summaries (OMB
Control No. 0920–0004, Exp. 10/31/
2020)—Reinstatement with Change—
National Center for Immunization and
Respiratory Diseases (NCIRD), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC requests a three-year approval for
the Reinstatement with Change of the
National Disease Surveillance Program
II—Disease Summaries information
collection. As with the previous
approval, these data are essential for
measuring trends in diseases, evaluating
the effectiveness of current preventive
strategies, and determining the need to
modify current preventive measures.
Influenza Virus, Caliciviruses,
Respiratory and Enteric Viruses are
associated with diseases in this
surveillance program. Proposed changes
in this Reinstatements with Change

E:\FR\FM\16SEN1.SGM

16SEN1